|
Form 4 Filings | Insider Buys | Significant Buys |
Penny Stocks Insider Buying |
Insider Sales |
| Insider Buy Sell Ratios | Stock Options |
Insider Trading Top Lists |
Insider Trading Graph View |
Insider Watch |
Sec Filings Insider Trading - Oxford Bioscience Partners Iv LP - Portfolio Holdings (Majority Ownership)
|
|
"Insiders might sell their shares for any number of reasons, but they buy them for only one:
they think the price will rise" - Peter Lynch ==>> What is insider trading>> |
OXFORD BIOSCIENCE PARTNERS IV LP: Insider Trading and Stock Options
Common stock purchase or sale:
| Transaction & Date | Reported Date |
Company | Symbol | Insider Relationship |
Shares Traded | Average Price | Total Amount |
Shares Ownership |
Filing |
| 2006-10-18 Purchase |
2006-10-20 6:11 pm | Cyberkinetics Neurotechnology Systems, Inc. | CYKN | OXFORD BIOSCIENCE PARTNERS IV LP MRNA FUND II LP OBP MANAGEMENT IV LP BARNES JEFFREY T CARTHY MARK FLEMING JONATHAN LYTTON MICHAEL WALTON ALAN G (10% owner) | 833,334 | $1.2 | $1,000,001 | 104,707 (Direct) | View |
| 2006-10-17 Purchase |
2006-10-19 5:23 pm |
Trubion Pharmaceuticals, Inc | TRBN | OXFORD BIOSCIENCE PARTNERS IV LP MRNA FUND II LP BARNES JEFFREY T CARTHY MARK FLEMING JONATHAN LYTTON MICHAEL WALTON ALAN G OBP MANAGEMENT IV LP (10% owner) | 41,614 | $13 | $540,982 | 413 (Direct) |
View |
| 2005-09-26 Purchase |
2005-09-28 8:08 pm | Cyberkinetics Neurotechnology Systems, Inc. | CYKN | OXFORD BIOSCIENCE PARTNERS IV LP MRNA FUND II LP OBP MANAGEMENT IV LP BARNES JEFFREY T CARTHY MARK FLEMING JONATHAN LYTTON MICHAEL WALTON ALAN G (10% owner) | 2,500,000 | $1.2 | $3,000,000 | 96,429 (Direct Indirect) | View |
| 2005-07-12 Purchase |
2005-07-14 7:36 pm |
Solexa, Inc. | SLXA | OXFORD BIOSCIENCE PARTNERS IV LP MRNA FUND II LP OBP MANAGEMENT IV LP BARNES JEFFREY T CARTHY MARK FLEMING JONATHAN LYTTON MICHAEL WALTON ALAN G (10% owner) | 550,000 | $4 | $2,200,000 | 30,235 (Direct Indirect) |
View |
| 2005-07-06 Purchase |
2005-07-08 4:51 pm | SIRNA THERAPEUTICS INC | RNAI | OXFORD BIOSCIENCE PARTNERS IV LP MRNA FUND II LP (10% owner) | 1,250,000 | $1.6 | $2,000,000 | 58,267 (Direct Indirect) | View |
| 2005-04-20 Purchase | 2005-04-21 1:43 pm |
ACADIA PHARMACEUTICALS INC | ACAD | OXFORD BIOSCIENCE PARTNERS IV LP OBP MANAGEMENT IV LP BARNES JEFFREY T CARTHY MARK FLEMING JONATHAN LYTTON MICHAEL WALTON ALAN G (10% owner) | 586,402 | $6.821 | $4,000,024 | 3,160,238 (Direct) | View |
| 2004-11-04 Purchase |
2004-11-08 5:51 pm | Cyberkinetics Neurotechnology Systems, Inc. | CYKN | OXFORD BIOSCIENCE PARTNERS IV LP MRNA FUND II LP OBP MANAGEMENT IV LP CARTHY MARK FLEMING JONATHAN WALTON ALAN G BARNES JEFFREY T LYTTON MICHAEL (10% owner) | 318,501 | $3 | $955,503 | 71,595 (Direct) | View |
| 2004-04-14- -2004-04-19 Purchase(A) |
2004-07-02 6:27 pm |
IMCOR PHARMACEUTICAL CO | ICPHC | OXFORD BIOSCIENCE PARTNERS IV LP (10% owner) | 36,916,285 | $0.4 | $14,766,514 | 43,333,382 (Direct) |
View |
| 2004-04-14- -2004-04-19 Purchase |
2004-06-17 5:47 pm |
IMCOR PHARMACEUTICAL CO | ICPHC | OXFORD BIOSCIENCE PARTNERS IV LP (10% owner) | 19,648,394 | $0.75 | $14,736,296 | 26,065,491 (Direct) |
View |
| 2004-06-02 Purchase | 2004-06-04 6:17 pm |
ACADIA PHARMACEUTICALS INC | ACAD | OXFORD BIOSCIENCE PARTNERS IV LP MRNA FUND II LP OBP MANAGEMENT IV LP FLEMING JONATHAN BARNES JEFFREY T CARTHY MARK LYTTON MICHAEL (10% owner) | 285,000 | $7 | $1,995,000 | 25,979 (Direct) | View |
| 2003-12-09 Sale |
2003-12-10 9:16 pm | SIRNA THERAPEUTICS INC | RNAI | OXFORD BIOSCIENCE PARTNERS IV LP (10% owner) | 655 | $6 | $3,930 | 37,719 (Direct Indirect) | View |
| 2003-11-26 Sale |
2003-12-01 3:06 pm |
SIRNA THERAPEUTICS INC | RNAI | OXFORD BIOSCIENCE PARTNERS IV LP (10% owner) | 3,948 | $6.003 | $23,699 | 37,726 (Direct Indirect) | View |
| 2003-11-25 Sale | 2003-11-26 3:22 pm | SIRNA THERAPEUTICS INC | RNAI | OXFORD BIOSCIENCE PARTNERS IV LP (10% owner) | 4,500 | $6.032 | $27,143 | 37,765 (Direct Indirect) |
View |
| 2003-11-20 Sale |
2003-11-21 2:16 pm |
SIRNA THERAPEUTICS INC | RNAI | OXFORD BIOSCIENCE PARTNERS IV LP (10% owner) | 500 | $6.062 | $3,031 | 37,810 (Direct Indirect) | View |
| 2003-11-18 Sale |
2003-11-20 4:04 pm | SIRNA THERAPEUTICS INC | RNAI | OXFORD BIOSCIENCE PARTNERS IV LP (10% owner) | 8,000 | $6.21 | $49,680 | 37,815 (Direct Indirect) |
View |
| 2003-11-14- -2003-11-17 Sale | 2003-11-18 6:17 pm | SIRNA THERAPEUTICS INC | RNAI | OXFORD BIOSCIENCE PARTNERS IV LP (10% owner) | 44,000 | $6.21 | $273,258 | 37,894 (Direct Indirect) | View |
| 2003-11-12- -2003-11-13 Sale |
2003-11-14 6:32 pm |
SIRNA THERAPEUTICS INC | RNAI | OXFORD BIOSCIENCE PARTNERS IV LP (10% owner) | 23,056 | $6.683 | $154,075 | 38,331 (Direct Indirect) | View |
| 2003-11-10 Sale |
2003-11-12 1:29 pm |
SIRNA THERAPEUTICS INC | RNAI | OXFORD BIOSCIENCE PARTNERS IV LP (10% owner) | 11,881 | $6.832 | $81,171 | 3,843,048 (Direct) |
View |
| 2003-11-06- -2003-11-07 Sale |
2003-11-10 9:09 pm | SIRNA THERAPEUTICS INC | RNAI | OXFORD BIOSCIENCE PARTNERS IV LP (10% owner) | 61,999 | $7.076 | $438,719 | 3,854,929 (Direct) | View |
(A) Indicate amendment filing.
Other purchase or sale (not a common stock or no ticker symbol):
| Transaction & Date |
Reported Date | Company | Symbol | Insider Relationship | Shares Traded |
Average Price | Total Amount |
Shares Ownership |
Filing |
| 2004-04-14- -2004-04-19 Sale(A) | 2004-07-02 6:27 pm | IMCOR PHARMACEUTICAL CO | ICPHC | OXFORD BIOSCIENCE PARTNERS IV LP (10% owner) | 12,588,368 | $0.4 | $5,035,347 | 0 (Direct) | View |
| 2004-04-14- -2004-04-19 Sale | 2004-06-17 5:47 pm | IMCOR PHARMACEUTICAL CO | ICPHC | OXFORD BIOSCIENCE PARTNERS IV LP (10% owner) | 12,558,149 | $0.75 | $9,418,612 | 0 (Direct) | View |
(A) Indicate amendment filing.
Other transactions:
| Transaction & Date | Reported Date |
Company | Symbol | Insider Relationship |
Shares Traded | Average Price |
Total Amount |
Shares Ownership |
Filing |
| 2006-10-23 Purchase | 2006-10-25 5:04 pm |
Trubion Pharmaceuticals, Inc | TRBN | OXFORD BIOSCIENCE PARTNERS IV LP MRNA FUND II LP BARNES JEFFREY T CARTHY MARK FLEMING JONATHAN LYTTON MICHAEL WALTON ALAN G OBP MANAGEMENT IV LP (10% owner) | 2,155,686 | $0 | $0 | 21,790 (Direct) |
View |
| 2006-01-18 Other |
2006-01-20 6:48 pm | Solexa, Inc. | SLXA | OXFORD BIOSCIENCE PARTNERS IV LP MRNA FUND II LP (Former 10% Owner) | 2,000,000 | $0 | $0 | 10,388 (Direct Indirect) | View |
| 2005-07-12 Option Award | 2005-07-14 7:36 pm |
Solexa, Inc. | SLXA | OXFORD BIOSCIENCE PARTNERS IV LP MRNA FUND II LP OBP MANAGEMENT IV LP BARNES JEFFREY T CARTHY MARK FLEMING JONATHAN LYTTON MICHAEL WALTON ALAN G (10% owner) | 2,006 | $0 | $0 | 30,255 (Direct Indirect) |
View |
| 2005-01-10 Option Award |
2005-02-17 2:33 pm | IMCOR PHARMACEUTICAL CO | ICPHC | OXFORD BIOSCIENCE PARTNERS IV LP (10% owner) | 49,786 | $0.35 | $17,425 | 44,564,652 (Direct) |
View |
| 2004-12-30 Exercise |
2005-01-04 7:04 pm | SIRNA THERAPEUTICS INC | RNAI | OXFORD BIOSCIENCE PARTNERS IV LP (10% owner) | 818,445 | $2.52 | $2,062,481 | 45,849 (Direct Indirect) |
View |
| 2004-06-02 Purchase | 2004-06-04 6:17 pm |
ACADIA PHARMACEUTICALS INC | ACAD | OXFORD BIOSCIENCE PARTNERS IV LP MRNA FUND II LP OBP MANAGEMENT IV LP FLEMING JONATHAN BARNES JEFFREY T CARTHY MARK LYTTON MICHAEL (10% owner) | 2,314,815 | $0 | $0 | 23,148 (Direct) | View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction & Date |
Reported Date | Exercisable Expiration | Company | Symbol | Insider Relationship |
Shares Traded |
Conversion Price |
Shares Ownership |
Filing |
| 2006-10-23 Purchase |
2006-10-25 5:04 pm |
N/A N/A | Trubion Pharmaceuticals, Inc | TRBN | OXFORD BIOSCIENCE PARTNERS IV LP MRNA FUND II LP BARNES JEFFREY T CARTHY MARK FLEMING JONATHAN LYTTON MICHAEL WALTON ALAN G OBP MANAGEMENT IV LP (10% owner) | 976,592 | $0 | 0 (Direct) |
View |
| 2006-10-23 Purchase | 2006-10-25 5:04 pm | N/A N/A | Trubion Pharmaceuticals, Inc | TRBN | OXFORD BIOSCIENCE PARTNERS IV LP MRNA FUND II LP BARNES JEFFREY T CARTHY MARK FLEMING JONATHAN LYTTON MICHAEL WALTON ALAN G OBP MANAGEMENT IV LP (10% owner) | 1,157,717 | $0 | 0 (Direct) | View |
| 2006-10-23 Purchase |
2006-10-25 5:04 pm | N/A N/A | Trubion Pharmaceuticals, Inc | TRBN | OXFORD BIOSCIENCE PARTNERS IV LP MRNA FUND II LP BARNES JEFFREY T CARTHY MARK FLEMING JONATHAN LYTTON MICHAEL WALTON ALAN G OBP MANAGEMENT IV LP (10% owner) | 9,800 | $0 | 0 (Direct) |
View |
| 2006-10-23 Purchase | 2006-10-25 5:04 pm |
N/A N/A | Trubion Pharmaceuticals, Inc | TRBN | OXFORD BIOSCIENCE PARTNERS IV LP MRNA FUND II LP BARNES JEFFREY T CARTHY MARK FLEMING JONATHAN LYTTON MICHAEL WALTON ALAN G OBP MANAGEMENT IV LP (10% owner) | 11,577 | $0 | 0 (Direct) | View |
| 2006-10-18 Purchase | 2006-10-20 6:11 pm | 2006-10-18 2011-10-18 |
Cyberkinetics Neurotechnology Systems, Inc. | CYKN | OXFORD BIOSCIENCE PARTNERS IV LP MRNA FUND II LP OBP MANAGEMENT IV LP BARNES JEFFREY T CARTHY MARK FLEMING JONATHAN LYTTON MICHAEL WALTON ALAN G (10% owner) | 412,528 | $1.4 | 412,528 (Direct) |
View |
| 2006-10-18 Purchase | 2006-10-20 6:11 pm |
2006-10-18 2011-10-18 | Cyberkinetics Neurotechnology Systems, Inc. | CYKN | OXFORD BIOSCIENCE PARTNERS IV LP MRNA FUND II LP OBP MANAGEMENT IV LP BARNES JEFFREY T CARTHY MARK FLEMING JONATHAN LYTTON MICHAEL WALTON ALAN G (10% owner) | 4,139 | $1.4 | 4,139 (Direct) | View |
| 2005-09-26 Purchase |
2005-09-28 8:08 pm |
2005-09-26 2010-09-26 |
Cyberkinetics Neurotechnology Systems, Inc. | CYKN | OXFORD BIOSCIENCE PARTNERS IV LP MRNA FUND II LP OBP MANAGEMENT IV LP BARNES JEFFREY T CARTHY MARK FLEMING JONATHAN LYTTON MICHAEL WALTON ALAN G (10% owner) | 1,237,583 | $1.6 | 1,237,583 (Direct) |
View |
| 2005-09-26 Purchase | 2005-09-28 8:08 pm |
2005-09-26 2010-09-26 | Cyberkinetics Neurotechnology Systems, Inc. | CYKN | OXFORD BIOSCIENCE PARTNERS IV LP MRNA FUND II LP OBP MANAGEMENT IV LP BARNES JEFFREY T CARTHY MARK FLEMING JONATHAN LYTTON MICHAEL WALTON ALAN G (10% owner) | 12,417 | $1.6 | 12,417 (Indirect) | View |
| 2005-07-29 Purchase | 2005-08-02 7:27 pm | 2005-10-17 2010-04-19 |
ACADIA PHARMACEUTICALS INC | ACAD | OXFORD BIOSCIENCE PARTNERS IV LP MRNA FUND II LP OBP MANAGEMENT IV LP BARNES JEFFREY T CARTHY MARK FLEMING JONATHAN LYTTON MICHAEL WALTON ALAN G (10% owner) | 89,900 | $8.148 | 236,500 (Direct) | View |
| 2005-07-12 Purchase |
2005-07-14 7:36 pm | 2006-01-08 2010-07-12 | Solexa, Inc. | SLXA | OXFORD BIOSCIENCE PARTNERS IV LP MRNA FUND II LP OBP MANAGEMENT IV LP BARNES JEFFREY T CARTHY MARK FLEMING JONATHAN LYTTON MICHAEL WALTON ALAN G (10% owner) | 272,268 | $5 | 272,268 (Direct) |
View |
| 2005-07-12 Purchase | 2005-07-14 7:36 pm | 2006-01-08 2010-07-12 |
Solexa, Inc. | SLXA | OXFORD BIOSCIENCE PARTNERS IV LP MRNA FUND II LP OBP MANAGEMENT IV LP BARNES JEFFREY T CARTHY MARK FLEMING JONATHAN LYTTON MICHAEL WALTON ALAN G (10% owner) | 2,732 | $5 | 2,732 (Indirect) | View |
| 2005-07-06 Purchase | 2005-07-08 4:51 pm | N/A N/A |
SIRNA THERAPEUTICS INC | RNAI | OXFORD BIOSCIENCE PARTNERS IV LP MRNA FUND II LP (10% owner) | 445,529 | $1.92 | 445,529 (Direct) |
View |
| 2005-07-06 Purchase | 2005-07-08 4:51 pm |
N/A N/A |
SIRNA THERAPEUTICS INC | RNAI | OXFORD BIOSCIENCE PARTNERS IV LP MRNA FUND II LP (10% owner) | 4,470 | $1.92 | 4,470 (Indirect) |
View |
| 2005-04-20 Purchase | 2005-04-21 1:43 pm |
2005-10-17 2010-04-19 | ACADIA PHARMACEUTICALS INC | ACAD | OXFORD BIOSCIENCE PARTNERS IV LP OBP MANAGEMENT IV LP BARNES JEFFREY T CARTHY MARK FLEMING JONATHAN LYTTON MICHAEL WALTON ALAN G (10% owner) | 146,600 | $8.148 | 146,600 (Direct) |
View |
| 2004-12-30 Expired |
2005-01-04 7:04 pm | 2003-02-11 2008-02-11 | SIRNA THERAPEUTICS INC | RNAI | OXFORD BIOSCIENCE PARTNERS IV LP (10% owner) | 810,315 | $2.52 | 0 (Direct) |
View |
| 2004-12-30 Purchase | 2005-01-04 7:04 pm |
2004-12-30 2005-02-07 |
SIRNA THERAPEUTICS INC | RNAI | OXFORD BIOSCIENCE PARTNERS IV LP (10% owner) | 810,315 | $2.52 | 810,315 (Direct) | View |
| 2004-12-30 Purchase |
2005-01-04 7:04 pm |
2004-12-30 2009-12-30 |
SIRNA THERAPEUTICS INC | RNAI | OXFORD BIOSCIENCE PARTNERS IV LP (10% owner) | 891,346 | $3.85 | 1,701,661 (Direct) |
View |
| 2004-12-30 Exercise |
2005-01-04 7:04 pm |
2004-12-30 2005-02-07 | SIRNA THERAPEUTICS INC | RNAI | OXFORD BIOSCIENCE PARTNERS IV LP (10% owner) | 810,315 | $2.52 | 891,346 (Direct) |
View |
| 2004-12-30 Expired | 2005-01-04 7:04 pm | 2003-02-11 2008-02-11 |
SIRNA THERAPEUTICS INC | RNAI | OXFORD BIOSCIENCE PARTNERS IV LP (10% owner) | 8,130 | $2.52 | 0 (Indirect) | View |
| 2004-12-30 Purchase |
2005-01-04 7:04 pm | 2004-12-30 2005-02-07 | SIRNA THERAPEUTICS INC | RNAI | OXFORD BIOSCIENCE PARTNERS IV LP (10% owner) | 8,130 | $2.52 | 8,130 (Indirect) | View |
| 2004-12-30 Purchase | 2005-01-04 7:04 pm |
2004-12-30 2009-12-30 |
SIRNA THERAPEUTICS INC | RNAI | OXFORD BIOSCIENCE PARTNERS IV LP (10% owner) | 8,943 | $3.85 | 17,073 (Indirect) |
View |
| 2004-12-30 Exercise | 2005-01-04 7:04 pm | 2004-12-30 2005-02-07 | SIRNA THERAPEUTICS INC | RNAI | OXFORD BIOSCIENCE PARTNERS IV LP (10% owner) | 8,130 | $2.52 | 8,943 (Indirect) | View |
| 2004-04-14 Purchase |
2004-07-02 6:27 pm | 2004-04-14 2009-04-14 |
IMCOR PHARMACEUTICAL CO | ICPHC | OXFORD BIOSCIENCE PARTNERS IV LP (10% owner) | 2,722,683 | $0.5 | 2,722,683 (Direct) | View |
| 2004-04-14 Purchase | 2004-06-17 5:47 pm |
2004-04-14 2009-04-14 | IMCOR PHARMACEUTICAL CO | ICPHC | OXFORD BIOSCIENCE PARTNERS IV LP (10% owner) | 1,452,098 | $1 | 1,452,098 (Direct) |
View |
| 2004-06-02 Purchase | 2004-06-04 6:17 pm |
N/A N/A | ACADIA PHARMACEUTICALS INC | ACAD | OXFORD BIOSCIENCE PARTNERS IV LP MRNA FUND II LP OBP MANAGEMENT IV LP FLEMING JONATHAN BARNES JEFFREY T CARTHY MARK LYTTON MICHAEL (10% owner) | 2,291,667 | $0 | 0 (Direct) |
View |
| 2004-06-02 Purchase | 2004-06-04 6:17 pm | N/A N/A |
ACADIA PHARMACEUTICALS INC | ACAD | OXFORD BIOSCIENCE PARTNERS IV LP MRNA FUND II LP OBP MANAGEMENT IV LP FLEMING JONATHAN BARNES JEFFREY T CARTHY MARK LYTTON MICHAEL (10% owner) | 23,148 | $0 | 0 (Direct) | View |
|
© 2005-2008 SecForm4.Com All rights reserved. Archives: 2008 2007 2006 2005 2004 2003 Fri, 21 Nov 2008 01:05:49 -0600 |
SEC is the U.S. Securities and Exchange Commission. EDGAR is a trademark of the SEC. SecForm4.Com is not affiliated with or approved by the U.S. Securities and Exchange Commission (SEC). Terms of Use | Privacy Statement | |